Asthma and allergy researchers have installed a pollen trap on the roof of the Auckland War Memorial Museum Tāmaki Paenga Hira to gather near-real-time data on airborne pollen and spores that can trigger a range of allergic reactions.
The government’s proposal to train an additional 95 doctors each year from 2025 to 2027, on top of the 50 additional places announced for 2024, has been met with mixed responses. An additional 285
Viridian Therapeutics announced trial results of its intravenously delivered treatment for chronic thyroid eye disease (TED), showing patients experienced reductions in proptosis and improvements in their clinical activity scores.
A novel synthetic peptide with anti-inflammatory properties potentially suited to DED management is the subject of a phase 2 clinical trial.
Māori are a third more likely to be admitted to hospital with injuries resulting from healthcare and are 43% more likely to be admitted because of healthcare complications compared with non-Māori, reported researchers from the University of Auckland.
Inflammation plays a key role in triggering and propagating dry eye disease (DED) via the ‘vicious circle’1. In severe cases, topical anti-inflammatory therapy may be indicated, but managing a patient’s meibomian gland dysfunction can often be sufficient to resolve ocular surface inflammation withou
US researchers found mice living in a drying atmosphere had healthier and more intact corneal surfaces when given the oral probiotic Limosilactobacillus reuteri than those given saline solution alone.
An Irish design graduate has developed a wearable device to reduce distracting visual stimuli for people with attention deficit hyperactivity disorder (ADHD). The 'Oasis' spectacles were designed by
A new report from the International Labour Organization (ILO) and the International Agency for the Prevention of Blindness (IAPB) is calling for better care of workers’ sight, given around 13 million
Okyo Pharma has announced plans to begin a phase 2 trial of OK-101, a non-opioid analgesic developed to reduce neuropathic corneal pain (NCP).
After successfully navigating Auckland’s extended Covid lockdown in 2021, the Ocular Surface Laboratory (OSL) team was excited to begin its long-awaited clinical trial to evaluate a single thermal pulsation treatment delivered by a novel handheld device (Systane iLux, Alcon) relative to standard-of-
Swimmers around New South Wales‘ coast and Israel’s Sea of Galilee are being warned of a high risk of ocular infections due to elevated levels of different waterborne parasites. Researchers from the
